- Report
- October 2024
- 193 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- September 2024
- 100 Pages
Global
From €5689EUR$5,950USD£4,762GBP
- Report
- August 2024
- 100 Pages
Global
From €5689EUR$5,950USD£4,762GBP
- Report
- March 2025
- 200 Pages
Global
From €4293EUR$4,490USD£3,593GBP
- Report
- May 2024
- 137 Pages
Global
From €6214EUR$6,499USD£5,201GBP
- Report
- April 2024
- 160 Pages
Global
From €4751EUR$4,969USD£3,977GBP
- Report
- December 2024
- 144 Pages
Global
From €14337EUR$14,995USD£12,001GBP
- Report
- September 2018
- 174 Pages
Global
From €1315EUR$1,375USD£1,100GBP
€2629EUR$2,750USD£2,201GBP
- Report
- March 2024
- 397 Pages
Global
From €7601EUR$7,950USD£6,363GBP
- Report
- March 2024
- 200 Pages
Global
From €3968EUR$4,150USD£3,321GBP
- Report
- October 2022
- 113 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Drug Pipelines
- September 2022
- 129 Pages
Global
From €14337EUR$14,995USD£12,001GBP
- Report
- March 2018
- 20 Pages
Global
From €9561EUR$10,000USD£8,003GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €478EUR$500USD£400GBP
- Report
- July 2022
- 220 Pages
Global
From €3413EUR$3,570USD£2,857GBP

Invega is a brand of antipsychotic medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a long-acting form of the drug paliperidone, which is a dopamine antagonist. Invega is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It is available in both oral and injectable forms.
Invega is one of the leading medications in the mental disorders drugs market. It is used to treat a wide range of mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder. It is also used to treat symptoms of psychosis, such as hallucinations and delusions. Invega is generally well-tolerated and has few side effects.
The Invega market is highly competitive, with several major pharmaceutical companies competing for market share. These include Janssen Pharmaceuticals, Pfizer, Eli Lilly, AstraZeneca, and Novartis. Each of these companies has its own range of products, including generic versions of Invega, as well as other antipsychotic medications. Show Less Read more